Subscribe To
MBIO / Best Penny Stocks To Buy? 5 To Watch With Potential Catalysts This Week
MBIO News
By GlobeNewsWire
September 7, 2023
Mustang Bio to Participate in Upcoming September 2023 Investor Conferences
WORCESTER, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focu more_horizontal
By Zacks Investment Research
June 13, 2023
Mustang (MBIO) Up 9% on Rare Blood Cancer Study's Upbeat Data
Updated data from a clinical study shows that treatment with Mustang Bio's (MBIO) CAR T cell therapy has achieved an overall response rate of 83% in p more_horizontal
By Zacks Investment Research
May 26, 2023
Wall Street Analysts Believe Mustang Bio, Inc. (MBIO) Could Rally 711.55%: Here's is How to Trade
The mean of analysts' price targets for Mustang Bio, Inc. (MBIO) points to a 711.6% upside in the stock. While this highly sought-after metric has not more_horizontal
By GuruFocus
May 17, 2022
Caribou Charges Ahead on Study Results
Shares of Caribou Biosciences Inc. ( CRBU , Financial) are up more than 46% since last Thursday, leading the way for several beaten-down biotechs that more_horizontal
By GlobeNewsWire
April 4, 2022
Mustang Bio to Present at the Virtual Fortress Biotech R&D Summit Hosted by B. Riley Securities
WORCESTER, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focu more_horizontal
By Benzinga
January 25, 2022
FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder
The FDA has issued a hold, pending Chemistry, Manufacturing & Controls (CMC) clearance, on Mustang Bio Inc's (NASDAQ: MBIO) Investigational New Dru more_horizontal
By Benzinga
January 25, 2022
FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder
The FDA has issued a hold, pending Chemistry, Manufacturing & Controls (CMC) clearance, on Mustang Bio Inc's (NASDAQ: MBIO) Investigational New Dru more_horizontal
By Benzinga
January 25, 2022
FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder
The FDA has issued a hold, pending Chemistry, Manufacturing & Controls (CMC) clearance, on Mustang Bio Inc's (NASDAQ: MBIO) Investigational New Dru more_horizontal